Drawing for MEDRADAR

USPTO serial 90450402

MEDRADAR

Reviewed by CopyMark Law Group

Reg. 6992318Status 700Registered
Filing date
Status date
Registration date
Feb 28, 2023
Examiner
KEATING, SHANNON B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MEDRADAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph E. Walsh, Jr.

Joseph E. Walsh, Jr. HARNESS, DICKEY & PIERCE, P.L.C.7700 BONHOMME, SUITE 400ST. LOUIS, MO 63105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009downloadable electronic data files featuring financial information in the medical, pharmaceutical, health care, and life sciences fields; downloadable applications and applets for mobile devices for database managementACTIVEJan 20, 2022
035Conducting business statistical data analysis and business data analysis via computer database; computerized database management and data processing services regarding available venture capital and financial information directed to medical, pharmaceutical, health care, and life sciences endeavors; market analysis and research servicesACTIVEJan 20, 2022
036Providing clients with financial information in the medical, pharmaceutical, health care, and life sciences fields; Providing a website for accessing information regarding available venture capital directed to medical, pharmaceutical, health care, and life sciences endeavors; providing a website for accessing information regarding investment opportunities in the medical, pharmaceutical, health care, and life sciences fields; providing a website for identifying and uncovering existing business and financial relationships among and between medical, pharmaceutical, health care and life sciences businesses, organizations and institutionsACTIVEJan 20, 2022
038Providing access to computer databases; transmission and delivery services, namely, providing secure delivery of digital media materials, digital files and digital media content via the Internet, wireless internet networks and systems and other computer and electronic communication networksACTIVEJan 20, 2022
042Providing search engines for the internet for obtaining financial information in the medical, pharmaceutical, health care, and life sciences fields; software as a service (SAAS) services featuring software for providing, collecting, analyzing pharmaceutical, medical, healthcare, and life sciences financial information; providing temporary use of an on-line database featuring financial information in the pharmaceutical, medical, healthcare, and life sciences fieldsACTIVEJan 20, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 28, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 28, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 26, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 25, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 13, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 13, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 13, 2022IUAFUSE AMENDMENT FILED—
Dec 13, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 14, 2022EX1GSOU EXTENSION 1 GRANTED—
Jun 14, 2022EXT1SOU EXTENSION 1 FILED—
Jun 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 14, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 14, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 14, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 14, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 14, 2021GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 14, 2021GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 14, 2021CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 17, 2021DOCKASSIGNED TO EXAMINER—
Apr 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 9, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance